Understanding NIBS: Non-Invasive Brain Stimulation

Non-invasive brain stimulation (NIBS) has become a cornerstone of modern clinical neuroscience. By modulating cortical excitability without surgery, NIBS techniques offer therapeutic options for depression, chronic pain, stroke rehabilitation and cognitive research.

What Counts as NIBS?

NIBS encompasses a family of technologies that deliver energy — magnetic or electrical — through the scalp to influence neural activity:

• rTMS — repetitive transcranial magnetic stimulation
• nTMS — navigated TMS with real-time coil tracking
• tDCS — transcranial direct current stimulation
• CES — cranial electrotherapy stimulation
• TES — transcranial electrical stimulation

rTMS and Closed-Loop rTMS

rTMS uses rapidly changing magnetic fields to induce currents in targeted cortical regions. Clinically, it is best established for treatment-resistant depression. Closed-loop rTMS takes this further by timing pulses to the patient's endogenous brain state, enabling genuinely personalized neuromodulation.

From rTMS to Targeted TMS

Standard rTMS relies on scalp landmarks. Targeted TMS, guided by neuronavigation (nTMS), maps the coil position to the individual's anatomy — improving precision and reproducibility, especially for motor and language mapping.

Electrical Stimulation: tDCS, CES and TES

tDCS delivers a low constant current to shift resting membrane potential. CES applies microcurrents for anxiety and insomnia. TES is the umbrella term covering tDCS, tACS and tRNS.

Why qEEG Matters

Quantitative EEG (qEEG) provides the biomarkers that make personalized neuromodulation possible — identifying which patients respond and guiding target selection for rTMS and tDCS.

Conclusion

NIBS is moving from one-size-fits-all protocols toward data-driven, personalized neuromodulation. Combining qEEG with targeted TMS and closed-loop rTMS is the next frontier.